It looks like Bayer got its bargain. In a move that has shocked most in the press by its size and scope, the company that acquired Monsanto for $63 billion will set aside a bit more than $10 billion to settle current and future claims that Monsanto’s flagship weed killer Roundup causes cancer.
When word of settlement negotiations first leaked, conversations seemed to hover around a ...
continue reading...